AVITA Medical, Inc. Quarterly Operating Income (Loss) in USD from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
AVITA Medical, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2018 to Q2 2024.
  • AVITA Medical, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$15.6M, a 39.9% decline year-over-year.
  • AVITA Medical, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$54.4M, a 66.2% decline year-over-year.
  • AVITA Medical, Inc. annual Operating Income (Loss) for 2023 was -$42.7M, a 55.1% decline from 2022.
  • AVITA Medical, Inc. annual Operating Income (Loss) for 2022 was -$27.5M, a 3.64% decline from 2021.
  • AVITA Medical, Inc. annual Operating Income (Loss) for 2021 was -$26.5M, a 37.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$54.4M -$15.6M -$4.46M -39.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$50M -$17.2M -$7.3M -73.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$42.7M -$12.3M -$6.37M -108% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 -$36.3M -$9.31M -$3.56M -61.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$32.7M -$11.2M -$4.8M -75.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$27.9M -$9.91M -$424K -4.47% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$27.5M -$5.91M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$5.75M +$201K +3.38% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$6.36M -$1.66M -35.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$9.49M -$3.5M -58.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 -$22.3M -$5.95M +$4.27M +41.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$26.5M -$4.7M +$8.32M +63.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$34.9M -$5.99M +$9.42M +61.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$44.3M -$5.63M +$4.96M +46.8% Oct 1, 2020 Dec 31, 2020 10-K 2021-08-26
Q3 2020 -$49.2M -$10.2M -$6.56M -179% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$42.7M -$13M -$5.53M -73.8% Apr 1, 2020 Jun 30, 2020 10-K 2021-08-26
Q1 2020 -$37.1M -$15.4M -$8.73M -131% Jan 1, 2020 Mar 31, 2020 10-K 2021-08-26
Q4 2019 -$28.4M -$10.6M -$4.29M -68.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-08-26
Q3 2019 -$24.1M -$3.66M +$1.4M +27.7% Jul 1, 2019 Sep 30, 2019 10-K 2021-08-26
Q2 2019 -$25.5M -$7.49M Apr 1, 2019 Jun 30, 2019 10-K 2020-08-27
Q1 2019 -$6.68M Jan 1, 2019 Mar 31, 2019 10-K 2020-08-27
Q4 2018 -$6.3M Oct 1, 2018 Dec 31, 2018 10-K 2020-08-27
Q3 2018 -$5.06M Jul 1, 2018 Sep 30, 2018 10-K 2020-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.